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Abstract
Metastatic tumor blood perfusion and interstitial fluid transport based on 3D microvas-
culature response to inhibitory effect of angiostatin are investigated. 3D blood flow, inter-
stitial fluid transport, and transvascular flow are described by the extended Poiseuille’s, 
Darcy’s, and Starling’s law, respectively. The simulation results demonstrate that angio-
statin has the capacity to regulate and inhibit the formation of new blood vessels and has 
an obvious impact on the morphology, growth rate, and the branches of microvascular 
network inside and outside the metastatic tumor. Heterogeneous blood perfusion, wide-
spread interstitial hypertension, and low convection within the metastatic tumor have 
obviously improved under the inhibitory effect of angiostatin, which suits well with the 
experimental observations. They can also result in more efficient drug delivery and pen-
etration into the metastatic tumor. The simulation results may provide beneficial infor-
mation and theoretical models for clinical research of antiangiogenic therapy strategies.
Keywords: blood perfusion, interstitial transport, metastatic tumor, angiostatin,  
3D simulation
1. Introduction
Cancer is the second leading cause of mortality worldwide [1], right behind cardiovascular 
disease. Metastatic tumors, the ultimate causes of death for the majority of cancer patients, are 
the important biological characteristics of malignant tumors. Metastasis occurs when cancer 
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cells spread from a primary tumor to distant and vital organs (secondary sites) in human body. 
Angiogenesis is necessary for tumor growth, invasion, and metastasis [2], since it supplies 
the nutrients and oxygen for continued tumor growth. The neovascularization accelerates the 
growth of tumor while simultaneously offering an initial route by which cancer cells can escape 
from a primary tumor to form metastatic tumor. Cancer cells migrate into the blood stream 
and surrounding tissues via microcirculation, then continue to grow giving rise to metastases 
[3]. The blood perfusion and interstitial fluid flow have been recognized as critical elements 
in metastatic tumor growth and vascularization [4]. However, tumor vessels are dilated, sac-
cular, tortuous, and heterogeneous in their spatial distribution. These abnormalities result in 
heterogeneity of blood flow and elevated interstitial fluid pressure (IFP), which forms a physi-
ological barrier to the delivery of therapeutic agents to tumors [5]. Abnormal microvasculature 
and microenvironment further lowers the effectiveness of therapeutic agents.
Experimental research showed that the primary tumor in the Lewis lung model system was 
capable of generating a factor which was named angiostatin later suppressing the neovas-
cularization and expansion of tumor metastases [6]. Angiostatin is a 38-kD internal peptide 
of plasminogen, which is a potent inhibitor of angiogenesis in vivo, and selectively inhibits 
endothelial cell (EC) proliferation and migration in vitro. Tumor cells express enzymatic 
activity which is capable of hydrolyzing plasminogen to generate angiostatin [7]. Angiostatin 
is then transported and accumulated in the blood circulation in excess of the stimulators and 
thus inhibiting angiogenesis of a metastatic tumor. Angiostatin, by virtue of its longer half-life 
in the circulation [8], reaches the vascular bed of metastatic tumor. As a result, growth of a 
metastasis is restricted by preventing and inhibiting angiogenesis within the vascular bed of 
the metastasis itself. A schematic diagram of this process is given in Figure 1. Indeed, anti-
angiogenic treatments directly targeting angiogenic signaling pathways as well as indirectly 
modulating angiogenesis show normalization of tumor microvasculature and microenviron-
ment at least transiently in both preclinical and clinical settings.
In spite of several mathematical models of metastatic tumors, there appears to be little in the lit-
erature by way of mathematical modeling of the mechanisms of antiangiogenic activity of angi-
ostatin on blood flow and interstitial fluid pressure in a metastatic tumor. Liotta et al. [9] first 
Figure 1. Schematic representation of angiostatin transported from a fully vascularized primary tumor to its relation to 
a distant secondary tumor.
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developed an experimental model to quantify some of the major processes initiated by tumor 
transplantation and culminating in pulmonary metastases. The study suggested that “dynam-
ics of hematogenously initiated metastases depended strongly on the entry rate of tumor cell 
clumps into the circulation, which in turn was intimately linked to tumor vascularization.” 
Later in the study, Liotta et al. [9] confirmed their former observation and raised the idea that 
“larger clumps produce significantly more metastatic foci than do smaller clumps matched for 
the number of cells.” Saidel et al. [10] proposed a lumped-parameter, deterministic model of 
the hematogenous metastatic process from a solid tumor, which provided a general theoretical 
framework for analysis and simulation. Numerical solutions of the model were in good agree-
ment with their experimental results [9]. The possibilities of anti-invasion and antimetastatic 
strategies in cancer treatment have bestowed an added preponderance with the keen interest in 
the mathematical modeling in the areas of tumor invasion and metastasis. Orme and Chaplain [11] 
presented a simple mathematical model of the vascularization and subsequent growth of a 
solid spherical tumor and gave a possible explanation for tumor metastasis, whereby tumor 
cells entered the blood system and secondary tumor may rise with the transportation func-
tion of blood. Sleeman and Nimmo [12] modified the model of fluid transport in vascular-
ized tumors by Baxter and Jain [13] to take tumor invasion and metastasis into consideration. 
Although these models did provide some features of tumor metastasis and interstitial fluid 
transportation such as perturbation analysis, they lacked in providing more detail information 
of metastatic tumor and as such were of limited predicted value. More realistic models of metas-
tasis and interstitial fluid transportation were developed to better understand its mechanism. 
Anderson et al. [14] presented a discrete model from the partial differential equations of the 
continuum models which implied that haptotaxis was important for tumor metastasis. Iwata 
et al. [15] proposed a partial differential equation (PDE) that described the metastatic evolution 
of an untreated tumor, and its predicted results agreed well with successive data of a clini-
cally observed metastatic tumor. Benzekry et al. [16] proposed an organism-scale model for the 
development of a population of secondary tumors that takes into account systemic inhibiting 
interactions among tumors due to the release of a circulating angiogenesis inhibitor. Baratchart 
et al. [17] derived a mathematical model of spatial tumor growth compared with experimental 
data and suggested that the dynamics of metastasis relied on spatial interactions between meta-
static lesions. Stéphanou et al. [18] investigated chemotherapy treatment efficiency by perform-
ing a Newtonian fluid flow simulation based on a study of vascular networks generated from 
a mathematical model of tumor angiogenesis. Wu et al. [19] extended the mathematical model 
into a 3D case to investigate tumor blood perfusion and interstitial fluid movements originat-
ing from tumor-induced angiogenesis. Soltani and Chen [20] first studied the fluid flow in a 
tumor-induced capillary network and the interstitial fluid flow in normal and tumor tissues. 
The model provided a more realistic prediction of interstitial fluid flow pattern in solid tumor 
than the previous models. Some related works have been done on tumor-induced angiogenesis, 
blood perfusion, and interstitial fluid flow in the tumor microenvironment by using 2D math-
ematical methods [5, 21–23]. In spite of the valuable body of work performed in simulation of 
blood perfusion, interstitial fluid flow, and metastasis, previous studies have not examined 
blood perfusion and interstitial fluid pressure in the metastatic tumor microcirculation based 
on the 3D microvascular network response to the inhibitory effect of angiostatin which plays a 
significant role in suppressing tumor growth and metastasis.
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Metastatic tumor blood perfusion and interstitial fluid transport based on 3D microvascula-
ture response to inhibitory effect of angiostatin are investigated for exploring the suppression 
of metastatic tumor growth by the primary tumor. The abnormal geometric and morpho-
logical features of 3D microvasculature network inside and outside the metastatic tumor, 
and relative complex and heterogeneous hemodynamic characteristics in the presence and 
absence of angiostatin can be studied in the 3D case. The simulation results may provide 
beneficial information and theoretical basis for clinical research on antiangiogenic therapy.
2. 3D mathematical models
2.1. Metastatic tumor angiogenesis
3D mathematical model we present in this section originates from the previous 2D tumor 
antiangiogenesis mathematical model [5, 21] describing how capillary networks form in a met-
astatic tumor in response to angiostatin released by a primary tumor. The conservation equa-
tion of endothelial cells (EC) indicates the migration of EC influenced mainly by four factors: 
random motility, inhibitory effect of angiostatin, chemotaxis, and haptotaxis. Subsequently, 
from a discretized form of the partial differential equations governing endothelial-cell motion, 
a discrete biased random-walk model will be derived enabling the paths of individual endo-
thelial cells located at the sprout tips, and hence the individual capillary sprouts, to be fol-
lowed. Hence, realistic capillary network structures were generated by incorporating rules for 
sprout branching and anastomosis. The generated microvascular network inside and outside 
the metastatic tumor in the presence of angiostatin and in the absence of angiostatin is shown 
in Figure 2. General morphological features of the network such as growth speed, capillary 
number, vessel branching order, and anastomosis density in/outside the metastatic tumor are 
consistent with the physiologically observed results, which indicate that angiostatin secreted 
by the primary tumor dose has an inhibitory effect on metastatic tumor [5, 11].
2.2. Blood perfusion
To calculate blood flow through a given 3D microvascular network of interconnected capil-
lary elements to the metastatic tumor, assuming flux conservation and incompressible flow at 
each junction where the capillary elements meet
  ∑ 
n=1
6
   Q 
 (l.m.j)  n ⋅  B  (l.m,j)  n  = 0 (1)
where  B 
 (l,m,j)  
n takes the integer 1 or 0, representing the connectivity between node  (l, m, j) and its 
adjacent node  n .  Q 
 (l,m,j)  
n is the flow rate from node  (l, m, j) to node  n and is given by  Q 
 (l.m.j)  
n  =  Q 
v, (l,m,j)  
n −  Q 
t, (l,m,j)  
n , 
where  Q 
v, (l,m,j)  
n is the vascular flow rate without fluid leakage, described locally by Poiseuille’s law
  Q 
v, (l.m,j)  n  =  
π  R 
n
 4( p v, (l,m,j)  −  p v, (n)  ) 
  ______________8  μ 
n
  Δ  L 
n
 
 (2)
and  Q 
t, (l,m,j)  
n is the transvascular flow rate, following Starling’s law
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  Q 
t, (l,m,j)  n  = 2π  R n  Δ  L n ⋅  L pv [ ( p ¯ v, (l,m,j)  n −  p ¯ i, (l,m,j)  n ) −  σ t ( π v −  π i ) ] (3)
where  p 
v, (l,m,j)  and  p v, (n)  are the intravascular pressure of node  (l, m, j) and node  n ;  p ¯ v, (l,m,j)  n is the mean pressure in vascular element  (l, m, j) ;  p ¯ 
i, (l,m,j)  
n is the mean interstitial pressure outside of vascular 
element  (l, m, j) .  μ 
n
 ,  R 
n
 , and  Δ  L 
n
 are the blood viscosity, radius, and length of the vessel element  n , 
respectively;  L 
pv
 is the hydraulic permeability of vascular wall;  σ 
t
 is the average osmotic reflec-
tion coefficient for plasma proteins;  π 
v
 and  π 
i
 are the colloid osmotic pressure of plasma and 
interstitial fluid.
2.3. Interstitial flow in metastatic tumor
Considering the metastatic tumor tissue as an isotropic porous medium, its interstitial flow is 
modeled by Darcy’s law [24]:
  u 
i
  = − κ ∇  p 
i
 (4)
where  u 
i
 is the interstitial fluid velocity;  κ is the hydraulic conductivity coefficient of the inter-
stitium;  p 
i
 is the interstitial pressure.
The continuity equation is given by:
Figure 2. The spatiotemporal dynamic growth of 3D microvascular networks inside and outside the metastatic tumor: 
(a–c) in the presence of angiostatin; (d–f) in the absence of angiostatin.
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v
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L
 (5)
where  ϕ 
v
  =  
 L 
pv
   S 
v
 
 
_____
V
 ( p v −  p i −  σ t ( π v −  π i ) ) is the fluid source term leaking from blood vessels. ϕ  L  =  
 L 
pL
   S 
L
 
 
_____
V
 ( p i −  p L ) is the lymphatic drainage term, which is proportional to the pressure difference between the inter-
stitium and the lymphatics.
Mass conservation at each junction where the interstitial fluid pressure satisfies equation:
  ∇ 2   p 
i
  =   α 2  __
 R 2 ( p i −  p ev ) ⋅ B (6)
where  p 
ev
  =  ( L pv   S v ( p v −  σ t ( π v −  π i ) ) +  L pL   S L   p L )  /  ( L pv   S v +  L pL   S L ) is the effective pressure and  α = R  √ ________________  ( L pv   S v +  L pL   S L )  / 𝜅V is the ratio of interstitial to vascular resistances to fluid flow.  L 
pL
 is the hydraulic permeability 
of lymphatic vessel wall.  S 
v
  / V and  S 
L
  / V are the surface areas of blood vessel wall and lymphatic 
vessel wall per unit volume of tissue. In the model,  L 
pL
   S 
L
  / V is assumed zero for tumor tissue, 
and given a uniform value for normal tissue referring to Baxter and Jain [13]. The continuity 
of pressure and flux on the interconnected boundary between the tumor and normal tissue 
 Γ :  p 
i
 |  Γ −   =  p i |  Γ +  ,  −  κ T  ∇  p i |  Γ −   = −  κ N  ∇  p i |  Γ +  ,  κ T , and  κ N are the hydraulic conductivity coefficients of nor-mal tissue and tumor tissue, respectively.
Table 1 shows the values of the parameters used in the microcirculation simulations.
3. Simulation results
3.1. 3D blood perfusion of metastatic tumor
We simulated the evolution of blood flow pressure in the presence/absence of angiostatin 
for 14 days representing the typical timescale for tumor vasculature to grow. Figure 3 shows 
Parameter Name Value Parameter Name Value
 σ 
t
 a Average osmotic 
reflection coefficient for 
plasma proteins
 8.7 ×  10 −5 T 
 0  .91 N 
 κ a Hydraulic conductivity 
coefficient of interstitium
 2.5 ×  10 −7 T   cm 2  / mmHg s 
 2.5 ×  10 −7 N   cm 2  / mmHg s 
 π 
v
 a Colloid osmotic 
pressure of plasma
 19  .8 T  mmHg 
 20 N  mmHg 
 ( 
 S 
v
 
 __
V) a Surface area per unit volume for transport in 
interstitium
 50 T   cm −1 
 50 N   cm −1 
 p 
L
 c Lymphatic pressure  0.5 N  mmHg   L pL   S L  _____V c Absorption capacity of 
lymphatic system
 0 T 1 / mmHg s 
 1.0 ×  10 −4 N 1 / mmHg s 
 π 
i
 a Colloid osmotic 
pressure of interstitium
 17  .3 T  mmHg 
 10 N  mmHg 
 L 
pv
 a Hydraulic permeability 
of vascular wall
 1.86 ×  10 −6 T  cm / mmHg s 
 3.6 ×  10 −8 N  cm / mmHg s 
 μ b Blood viscosity  1.0 cP 
aJain et al. [5].
bStephanou et al. [18].
cZhao et al. [25].
Subscript “N” and “T” represents the values in normal and tumor tissues, respectively.
Table 1. Baseline parameter values used in the simulations.
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the snapshots of the pressure profiles of blood flow through each vessel segment in a three-
dimensional microvascular networks. We keep the inlet pressure and outlet pressure across 
parent vessel fixed at 25 and 16 mmHg [25] in the simulation, in accordance with physiologi-
cal values at the capillary scale. Figure 3 highlights a direct comparison of blood pressure 
distributions (Figure 3a–c shows the blood pressure distribution in the presence of angio-
statin, Figure 3d–f shows the blood pressure distribution in the absence of angiostatin). We 
observe that the overall blood pressure is higher in the presence of angiostatin than that 
in the absence of angiostatin over the same growth duration. The blood flow distribution 
is complex and chaotic which makes the variety of blood pressure small in the interior of 
the metastatic tumor compared to its exterior, contributing to the difficulties of efficient 
drug delivery in metastatic tumor. In the presence of angiostatin, the pressure-flows within 
some of the daughter vessels are elevated from the branching points to the metastatic tumor 
surface which provides effective blood perfusion and thus efficient therapeutic agents to 
the tumor. The simulation results indicate that blood perfusion varies significantly with 
the complex and chaotic three-dimensional microvascular networks inside and outside the 
metastatic tumor. The poor blood perfusion can be improved through the increased intra-
vascular pressure with the presence of angiostatin. These results suggest that the inhibitory 
effect of angiostatin can affect the distribution of blood flow pressure and improve drug 
delivery to tumor.
Figure 3. Simulations of blood pressure through 3D microvascular networks over time: (a–c) example simulation with 
angiostatin; (d–f) example simulation without angiostatin. Simulation domain is  [0, 1] ×  [0, 1] ×  [0, 1] . Blood enters the 
networks at the end of the parent vessel  (x = 0, y = 0, z = 0.5) , distributes throughout the capillary network, leaves 
from the end of the parent vessel  (x = 0, y = 1, z = 0.5) .
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3.2. 3D interstitial fluid flow of metastatic tumor
Figure 4 shows the distribution of interstitial fluid pressure (IFP) within the metastatic tumor 
under the two mentioned situations. From the simulation results, we obtain that maximum IFP 
near the tumor center significantly dropped from 3.3, 11.48, and 11.53 to 0, 4.7, and 10.3 mmHg 
Figure 4. Interstitial fluid pressure distributions within the metastatic tumor: (a–c) in the presence of angiostatin; (d–f) 
in the absence of angiostatin on the same other conditions.
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with the presence of angiostatin at t = 3, 7 and 14 days, respectively, which indicated the IFP 
plateau is well relieved. As the growth days increase, IFP gradually elevates throughout the 
3D metastatic tumor and the high pressure zone is at the center of the tumor and diminishes 
to the periphery and later becomes flatter. Comparing Figure 4a–c to Figure 4d–f, we come to 
conclude that angiostatin decreases the high IFP in the tumor, thus with the lower transvascu-
lar pressure in the 3D heterogeneous capillary networks, leading to an significantly improved 
situation for interstitial convection which plays a significant role in nonuniform distribution 
of drug delivery to the metastatic tumor. These results provide important references for cancer 
prevention and treatment. Furthermore, antiangiogenic therapies can normalize tumor vascu-
lature and microenvironment, at least transiently in both preclinical and clinical settings [5].
4. Conclusion
The inhibitory effect of angiostatin on the growth of metastatic tumor has been observed in 
some clinical and experimental malignancies. In this chapter, we develop three-dimensional 
mathematical models describing the metastatic tumor microvasculature and microenvironment 
to investigate the inhibitory effect of antiangiogenic factor angiostatin secreted by the primary 
tumor on metastatic tumor angiogenesis, blood perfusion, and interstitial fluid flow. Simulation 
results demonstrate that angiostatin has an obvious impact on the morphology, expansion speed, 
capillary number, and vessel branching order inside and outside the metastatic tumor. 2D and 
3D mathematical models of tumor antiangiogenesis predict similar morphological behavior, 
such as vessels’ length, branching patterns, anastomosis density, or geometric distribution, for 
metastatic tumor angiogenesis under the inhibitory efficiency of angiostatin. However, capil-
lary number and microvascular density due to space growth of vessel networks are increased 
in the 3D model. Furthermore, the simulations reflect the influences of heterogeneous blood 
perfusion, widespread interstitial hypertension, and low convection within the 3D metastatic 
tumor by carrying out a comparative study relating to the inhibitory effect of angiostatin. We 
find that 2D antiangiogenesis model may be well suited to studying morphological behavior 
of vessel networks in the metastatic tumor, but 3D antiangiogenesis model can better analyze 
blood perfusion, interstitial fluid flow, or oxygen and nutrient transport within the metastatic 
tumor microenvironment based on its more realistic 3D microvascular networks. Although 
3D simulation results are consistent with the experimental observed facts and can provide 
more detailed space information, however, angiogenesis and hemodynamics in the metastatic 
tumor by the antiangiogenic therapy are very complex. To further research tumor angiogenic 
mechanisms and help to improve antiangiogenic cancer therapy, more realistic features and 
complex biology factors need to be incorporated within the 3D model, such as the anatomy 
and physiology of the metastatic tumor, drug delivery of antiangiogenic therapy, behaviors of 
cells adhesion and interaction and coupled with the various factors or other therapy strategies.
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